Hemodynamic Effects of Spironolactone in Patients With Heart Failure

NACompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

February 28, 2003

Primary Completion Date

October 31, 2006

Study Completion Date

October 31, 2006

Conditions
Congestive Heart Failure
Interventions
DRUG

Spironolactone

100 mg tablet of Spironolactone (Aldactone) by mouth with half a glass of water.

Trial Locations (1)

43614

Medical University of Ohio, Toledo

All Listed Sponsors
lead

University of Toledo Health Science Campus

OTHER

NCT00860340 - Hemodynamic Effects of Spironolactone in Patients With Heart Failure | Biotech Hunter | Biotech Hunter